John Lettieri to Pyridines
This is a "connection" page, showing publications John Lettieri has written about Pyridines.
Connection Strength
0.554
-
Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects. Cancer Chemother Pharmacol. 2018 01; 81(1):195-206.
Score: 0.501
-
Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics. Cancer Chemother Pharmacol. 2006 May; 57(5):685-92.
Score: 0.054